[PDF] Top 20 <p>Alkaptonuria: Current Perspectives</p>
Has 10000 "<p>Alkaptonuria: Current Perspectives</p>" found on our website. Below are the top 20 most common "<p>Alkaptonuria: Current Perspectives</p>".
<p>Alkaptonuria: Current Perspectives</p>
... Alkaptonuria (AKU; OMIM 203500) is a classic example of a rare monogenic autosomal-recessive disease, characterized by high circulating homogentisic acid (HGA). 1 In AKU, mutations of a gene coding for ... See full document
11
<p>Atrioventricular Nodal Reentrant Tachycardia: Current Perspectives</p>
... Abstract: Atrioventricular nodal reentrant tachycardia (AVNRT) is the most common, highly symptomatic paroxysmal supraventricular tachycardia. Despite pharmacological treat- ment and vagal maneuvers for acute ... See full document
6
<p>Metabolic Dysfunction and Asthma: Current Perspectives</p>
... discuss current perspectives regarding metabolic dysfunction in asthma, from obesity-related asthma to other metabolic conditions and the role of current pharmacological therapeutic strategies and ... See full document
11
<p>Pharmacogenomics In Pharmacy Practice: Current Perspectives</p>
... Pharmacist ’ s role in patient care has evolved and become the cornerstone in different specialties such as pharmacoki- netics, anticoagulation, antimicrobial stewardship, and med- ication therapy management (MTM). 14–17 ... See full document
8
<p>Medullary Sponge Kidney: Current Perspectives</p>
... Abstract: Medullary Sponge Kidney (MSK) disease is a rare congenital malformation of the distal nephron where cystic dilatation is appreciable in the collecting ducts and renal papillae. Most cases of the malformation ... See full document
6
<p>Cytokine Release Syndrome: Current Perspectives</p>
... the current de fi nition of CRS proposed by ASTCT and applies to not only CART cell therapy but to any therapy using immune effector cell activation as its primary mechanism of ... See full document
10
<p>Post-Transfusion Purpura: Current Perspectives</p>
... Abbreviations: PLT, platelet; PTP, post transfusion purpura; ITP, immune thrombocytopenic purpura; DITP, drug-induced thrombocytopenia; MAHA, microangiopathic hemolytic anemia; H/PF-4, h[r] ... See full document
11
<p>Vulvar Lichen Sclerosus: Current Perspectives</p>
... of a combination of PRP and fat-derived mesenchymal cells in 15 women with vulvar LS. The authors reported that all 15 patients had complete resolution of pain and symptoms. 66 However, a signi fi cant limitation of the ... See full document
10
<p>Transcranial Direct Current Stimulation in Patients with Anxiety: Current Perspectives</p>
... direct current stimulation (tDCS) has arisen as a promising tool and has been proven to be safe and well tolerated for the treatment of many diseases, including chronic pain, depres- sion, and ... See full document
9
<p>Management of recurrent nasopharyngeal carcinoma: current perspectives</p>
... A phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemo- therapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma. Vermo[r] ... See full document
9
<p>Blood Biomarkers of Uveal Melanoma: Current Perspectives</p>
... To overcome these limitations, immunomagnetic classi fi - cation particles with anti-melanoma antibodies, which recog- nized human high molecular weight-melanoma-associated antigen (HMW-MAA), have been used. Ulmer and ... See full document
13
<p>Optimal Management of Acromioclavicular Dislocation: Current Perspectives</p>
... Chronic ACJ instability is a challenging injury to treat for orthopedic surgeons. It can occur from delayed initial or failed non-operative or operative treatment of AC joint dislocations. It is widely accepted that the ... See full document
18
<p>Severe alcoholic hepatitis: current perspectives</p>
... low in patients with severe AH at baseline. A year after FMT, there was a signi fi cant reversal between the two, along with coexistence of donor and recipient species at 6 – 12 months post- FMT. This meant that new ... See full document
12
<p>Brittle cornea syndrome: current perspectives</p>
... Brittle cornea syndrome: case report with novel muta- tion in the PRDM5 gene and review of the literature. Case Rep Ophthalmol Med[r] ... See full document
6
<p>Current perspectives in Bietti crystalline dystrophy</p>
... Regarding the most common mutations in occidental patients, c.1393A>G [p.(R465G)] is predicted to generate an aggressive phenotype of BCD, according to the bioin- formatics tools that evaluate the impact of the ... See full document
21
<p>Prune belly syndrome: current perspectives</p>
... Orchidopexy can be performed at the same time as other surgical procedures, such as appendicovesicostomy and abdominoplasty, 50 to limit the number of general anesthetics. This may be of particular bene fi t in children ... See full document
7
<p>Immunotherapy for Medulloblastoma: Current Perspectives</p>
... Most of our current knowledge of CNS immunology is based on glioma research, which showed a de fi cient immune response in patients and animal models with gliomas. 2,18–20 Similarly, immunosuppression was fi rst ... See full document
21
<p>Familial Pancreatic Cancer: Current Perspectives</p>
... of multiple atypical nevi progressing to melanoma. 18 Patients with FAMMM have a 13-46-fold increased risk of pancreatic cancer compared to the general population, and increased incidence of other cancers such as breast, ... See full document
16
<p>HIV-Associated Histoplasmosis: Current Perspectives</p>
... Histoplasmosis, an underdiagnosed disease affecting people living with HIV/ AIDS in Brazil: results of a Multicenter Prospective Cohort Study Using both classical mycology tests and hist[r] ... See full document
13
<p>Enthesitis-related arthritis: current perspectives</p>
... In a child with JIA, ERA requires the presence of arthritis along with enthesitis or the presence of either arthritis or enthesitis along with any of the two following features: uveit[r] ... See full document
13
Related subjects